Metacrine, Inc. (NASDAQ:MTCR – Get Rating) was the recipient of a large decrease in short interest in February. As of February 28th, there was short interest totalling 465,600 shares, a decrease of 20.9% from the February 13th total of 588,600 shares. Based on an average daily volume of 3,470,000 shares, the short-interest ratio is presently […]